Interpace Diagnostics Group(DE:PF4)
€6.400.00 (0.00%)
DE:PF4
Interpace Diagnostics Group Revenue
€6.40
At close:0.00 (0.00%)
Interpace Diagnostics Group (PF4) Revenue
0 Followers
Interpace Diagnostics Group Revenue
Interpace Diagnostics Group had a revenue of 9.13M in the quarter ending Jun 30, 2026, with 1.10%. This bring the company's revenue in the last twelve months to 36.14M, Decreased 0.28%. In the fiscal year ending Dec 31, 2025, Interpace Diagnostics Group had annual revenue of 38.73M with -17.47% growth.
- Revenue (ttm)
- 36.14M
- Revenue Growth
- -26.06%
- P/S Ratio
- 0.88
- Revenue/Employee
- EUR 379,686
- Employees
- 102
- Market Cap
- EUR 34.04M
Revenue Chart
Interpace Diagnostics Group Revenue - Annual
Revenue History
| Fiscal End Date | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 38.73M | -8.20M | -17.47% |
| Dec 31, 2024 | 46.93M | 6.71M | 16.69% |
| Dec 31, 2023 | 40.21M | 8.38M | 26.31% |
| Dec 31, 2022 | 31.84M | -9.48M | -22.94% |
| Mar 31, 2022 | 41.31M | 8.92M | 27.52% |
| Mar 31, 2021 | 32.40M | 8.32M | 34.55% |
| Mar 31, 2020 | 24.08M | 2.18M | 9.97% |
| Dec 31, 2018 | 21.90M | 6.00M | 37.74% |
| Dec 31, 2017 | 15.90M | ― | ― |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.